AOU Sassari - Ospedale SS. Annunziata

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Familial hypercholesterolaemia1 trial
• Neuroendocrine tumours1 trial

Phase

• Phase 21 trial

Status

• Active, not recruiting1 trial
• Not yet recruiting1 trial

Lead sponsor

• Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 trial
• Gruppo Oncologico Italiano di Ricerca Clinica1 trial

Running trials

• Recruiting

  Durvalumab With Carboplatin and Etoposide Chemotherapy in Pulmonary Large-cell Neuroendocrine Carcinoma (LCNEC)

  NCT06418087· Phase 2· Gruppo Oncologico Italiano di Ricerca Clinica· Source

  Contact: Antonio Pazzola

• Active, not recruiting

  Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia

  NCT04579367· Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Neuroendocrine tumours1 recruiting